Drug Trial Radar · NCT07760961
Effect of Mizagliflozin on Hypoglycemia in Patients With Post-Bariatric Hypoglycemia
Last checked: Nov 20, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
36
Planned (sponsor's estimate)
Start
Oct 20, 2026
Primary completion
Oct 2027
Study completion Jan 2028
Sponsor
- Lead sponsor
- Vogenx, Inc.Industry
- Sponsor type
- Industry
- First posted
- Aug 12, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
VGX-001-013 (EMERGE) is a Phase 2b study to evaluate an investigational new drug, mizagliflozin, for safety, tolerability and its ability to prevent low blood sugar in patients with post-bariatric hypoglycemia.
Conditions
- Postbariatric Hypoglycemia
Interventions
Mizagliflozin 5 mgDrug
5mg mizagliflozin capsules orally administered TID for 28 days
Mizagliflozin 10 mgDrug
10mg mizagliflozin capsules orally administered TID for 28 days
PlaceboDrug
Placebo capsules orally administered TID for 28 days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of combined Level 2 (as measured by self-monitored blood glucose) and Level 3 hypoglycemic events (as measured by diary entry and adjudicated)Time frame: During the double-blind treatment period (approximately 28 days)
Locations
11 sites in 1 country. Site status is shown where the registry gives one.
Exalt Clinical Research
Chula Vista, California · Recruiting
Stanford
Palo Alto, California · Not yet recruiting
U Colorado- Anschutz Medical Campus
Aurora, Colorado · Not yet recruiting
DM Clinical- Miami
Doral, Florida · Not yet recruiting
Georgia Clinical Research
Lawrenceville, Georgia · Not yet recruiting
Centricity Research
Morehead City, North Carolina · Recruiting
Penn Medicine
Philadelphia, Pennsylvania · Not yet recruiting
Vanderbilt Weight Loss Center
Nashville, Tennessee · Not yet recruiting
DM Clinical- Irving
Irving, Texas · Not yet recruiting
UT San Antonio
San Antonio, Texas · Not yet recruiting
Texas Valley Clinical Research
Weslaco, Texas · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.